Autoimmune Disease Diagnostic Market, By Disease, Tests Type, Regions, Global Forecast
Autoimmune disease refers to disease where immune system produces antibodies that kill or attack healthy cells or tissues. The immune system work is to provide protection against germs such as bacteria and virus. In autoimmune disease immune system wrongly attacks patients body. According to American Autoimmune Related Diseases Association, autoimmune disease affects fifty million Americans in which 25% are male and 75% are female. The Global Autoimmune Disease Diagnostic Market is expected to surpass US$ 18 Billion by the year end of 2025.
Although there are 80 Types of Autoimmune Diseases, but 14 most Common Autoimmune Diseases are as follows:
Rheumatoid Arthritis, Psoriasis/psoriatic arthritis, Multiple sclerosis, Type 1 diabetes, Inflammatory bowel disease, Systemic Lupus Erythematosus (SLE), Addison’s disease, Sjögren’s syndrome, Graves’ disease, Hashimoto’s thyroiditis, Myasthenia gravis, Autoimmune vasculitis, Celiac disease, Pernicious anemia.
Factors Driving the Autoimmune Disease Diagnostic Market
Rising technological advancement in diagnostic, increasing patient awareness towards early diagnostic of disease, increasing government healthcare expenditure, increasing per capita expenditure on health, favorable government policies, industry positive initiative towards autoimmune disease and rising research & development on autoimmune will further propel the market of autoimmune disease diagnostic market in the future course of time.
Renub Research report titled “Autoimmune Disease Diagnostic Market, By Disease (Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others), Localized], Tests Type (Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C-Reactive Protein Tests, Urinalysis, Comprehensive Metabolic Panel, Others) Regions (North America, Europe, Asia-Pacific & Rest of World), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories) Global Forecast” provides a complete analysis of Global Autoimmune Disease Diagnostic Market.
Segment Insight by Disease
In this report, we have categorized the autoimmune disease diagnostic market on the basis of disease into two parts; Systemic autoimmune disease diagnostics and Localized autoimmune disease diagnostics. Systemic autoimmune disease diagnostics market are further fragmented into three parts; Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Rheumatoid Arthritis. In addition, we have also explained the technological development of autoimmune diagnostic.
Autoantibody Tests is one of the Largest Test of Autoimmune Disease Diagnostic Tests
In this report, we have categorized the autoimmune disease diagnostic market by test type into seven parts along with comprehensive assessment and factor that will boost the diagnostic test market. These tests are Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C - reactive protein Tests, Urinalysis and Comprehensive Metabolic Panel.
Regional Insight – North America is the Most Important Region for Autoimmune Disease Diagnostic Market
In this report, we have segmented the autoimmune disease diagnostic test market on the basis of four important regions; North America, Europe, Asia-Pacific and ROW. In addition, we have also done the multi-factor analysis for regional growth of autoimmune disease diagnostic market.
Companies Analysis
Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories are some of the top companies operating in the global autoimmune disease diagnostic; which has been studied thoroughly in the report.
All the 7 Companies Studied in the Report have been Studied from 3 Points
Autoimmune Disease Diagnostic Segments Covered in the Report:
Although there are 80 Types of Autoimmune Diseases, but 14 most Common Autoimmune Diseases are as follows:
Rheumatoid Arthritis, Psoriasis/psoriatic arthritis, Multiple sclerosis, Type 1 diabetes, Inflammatory bowel disease, Systemic Lupus Erythematosus (SLE), Addison’s disease, Sjögren’s syndrome, Graves’ disease, Hashimoto’s thyroiditis, Myasthenia gravis, Autoimmune vasculitis, Celiac disease, Pernicious anemia.
Factors Driving the Autoimmune Disease Diagnostic Market
Rising technological advancement in diagnostic, increasing patient awareness towards early diagnostic of disease, increasing government healthcare expenditure, increasing per capita expenditure on health, favorable government policies, industry positive initiative towards autoimmune disease and rising research & development on autoimmune will further propel the market of autoimmune disease diagnostic market in the future course of time.
Renub Research report titled “Autoimmune Disease Diagnostic Market, By Disease (Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others), Localized], Tests Type (Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C-Reactive Protein Tests, Urinalysis, Comprehensive Metabolic Panel, Others) Regions (North America, Europe, Asia-Pacific & Rest of World), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories) Global Forecast” provides a complete analysis of Global Autoimmune Disease Diagnostic Market.
Segment Insight by Disease
In this report, we have categorized the autoimmune disease diagnostic market on the basis of disease into two parts; Systemic autoimmune disease diagnostics and Localized autoimmune disease diagnostics. Systemic autoimmune disease diagnostics market are further fragmented into three parts; Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Rheumatoid Arthritis. In addition, we have also explained the technological development of autoimmune diagnostic.
Autoantibody Tests is one of the Largest Test of Autoimmune Disease Diagnostic Tests
In this report, we have categorized the autoimmune disease diagnostic market by test type into seven parts along with comprehensive assessment and factor that will boost the diagnostic test market. These tests are Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C - reactive protein Tests, Urinalysis and Comprehensive Metabolic Panel.
Regional Insight – North America is the Most Important Region for Autoimmune Disease Diagnostic Market
In this report, we have segmented the autoimmune disease diagnostic test market on the basis of four important regions; North America, Europe, Asia-Pacific and ROW. In addition, we have also done the multi-factor analysis for regional growth of autoimmune disease diagnostic market.
Companies Analysis
Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories are some of the top companies operating in the global autoimmune disease diagnostic; which has been studied thoroughly in the report.
All the 7 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Business Strategy/Mergers & Acquisition
- Financial Insight
Autoimmune Disease Diagnostic Segments Covered in the Report:
- Systemic autoimmune disease diagnostics market
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Systemic Lupus Erythematosus (SLE)
- Others
- Localized autoimmune disease diagnostics
- Inflammatory Bowel Disease
- Type 1 Diabetes
- Thyroid
- Other Localized Autoimmune Diseases
- North America
- Europe
- Asia-Pacific
- Rest of World
- Abbott Laboratories
- Siemens Healthineers
- Roche Diagnostics
- EUROIMMUN AG
- bioMerieux SA
- Quest Diagnostic
- Bio-Rad Laboratories
1. EXECUTIVE SUMMARY
2. GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
3. MARKET SHARE – GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC
3.1 By Disease – Global Autoimmune Diseases Diagnostic
3.2 By Disease – Systemic Autoimmune Diseases Diagnostic
3.3 By Region – Global Autoimmune Diseases Diagnostic
4. BY DISEASE - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
4.1 Systemic Autoimmune Disease
4.1.1 Rheumatoid Arthritis
4.1.2 Ankylosing Spondylitis
4.1.3 Systemic Lupus Erythematosus (SLE)
4.1.4 Others
4.2 Localized Autoimmune Disease Diagnostics
4.2.1 Inflammatory Bowel Disease
4.2.2 Type 1 Diabetes
4.2.3 Thyroid
4.2.4 Other Localized Autoimmune Diseases
5. BY TEST TYPE - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
5.1 Autoantibody Tests
5.2 Antinuclear Antibody (ANA) Tests
5.3 Complete Blood Count Tests
5.4 Erythrocyte Sedimentation Rate Tests
5.5 C-reactive protein (CRP) Tests
5.6 Urinalysis Tests
5.7 Comprehensive Metabolic Panel Tests
5.8 Others Tests
6. BY REGION - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Rest of the World (ROW)
7. ABBOTT LABORATORIES – COMPANY ANALYSIS
7.1 Overview
7.2 Business Strategy
7.2.1 Point A
7.2.2 Point B
7.2.3 Point D
7.2.4 Point E
7.3 Financial Insight
8. SIEMENS HEALTHINEERS – COMPANY ANALYSIS
8.1 Overview
8.2 Business Strategy
8.2.1 Point A
8.2.2 Point B
8.2.3 Point C
8.3 Financial Insight
9. ROCHE DIAGNOSTICS – COMPANY ANALYSIS
9.1 Overview
9.2 Roche Holding AG Key Development
9.3 Business Strategy
9.3.1 Point A
9.3.2 Point B
9.3.3 Point C
9.4 Financial Insight
10. EUROIMMUN AG – COMPANY ANALYSIS
10.1 Overview
10.2 Business Strategy
10.2.1 Point A
10.2.2 Point B
10.3 Financial Insight
11. BIOMERIEUX SA – COMPANY ANALYSIS
11.1 Overview
11.2 Business Strategy
11.2.1 Point A
11.2.2 Point B
11.2.3 Point C
11.3 Financial Insight
12. QUEST DIAGNOSTIC – COMPANY ANALYSIS
12.1 Overview
12.2 Business Strategy
12.2.1 Point A
12.2.2 Point B
12.2.3 Point C
12.2.4 Point D
12.2.5 Point E
12.3 Financial Insight
13. BIO-RAD LABORATORIES – COMPANY ANALYSIS
13.1 Overview
13.2 Business Strategy
13.2.1 Point A
13.2.2 Point B
13.2.3 Point C
13.3 Financial Insight
14. GROWTH DRIVERS
14.1 Rising Incidence of Autoimmune Diseases
14.2 High Occurrence of Rheumatoid Arthritis
15. CHALLENGES
15.1 Industry Challenges by Product Differentiation
15.2 High Costs of Equipment for Diagnosis of Autoimmune Diseases
2. GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
3. MARKET SHARE – GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC
3.1 By Disease – Global Autoimmune Diseases Diagnostic
3.2 By Disease – Systemic Autoimmune Diseases Diagnostic
3.3 By Region – Global Autoimmune Diseases Diagnostic
4. BY DISEASE - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
4.1 Systemic Autoimmune Disease
4.1.1 Rheumatoid Arthritis
4.1.2 Ankylosing Spondylitis
4.1.3 Systemic Lupus Erythematosus (SLE)
4.1.4 Others
4.2 Localized Autoimmune Disease Diagnostics
4.2.1 Inflammatory Bowel Disease
4.2.2 Type 1 Diabetes
4.2.3 Thyroid
4.2.4 Other Localized Autoimmune Diseases
5. BY TEST TYPE - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
5.1 Autoantibody Tests
5.2 Antinuclear Antibody (ANA) Tests
5.3 Complete Blood Count Tests
5.4 Erythrocyte Sedimentation Rate Tests
5.5 C-reactive protein (CRP) Tests
5.6 Urinalysis Tests
5.7 Comprehensive Metabolic Panel Tests
5.8 Others Tests
6. BY REGION - GLOBAL AUTOIMMUNE DISEASES DIAGNOSTIC MARKET
6.1 North America
6.2 Europe
6.3 Asia Pacific
6.4 Rest of the World (ROW)
7. ABBOTT LABORATORIES – COMPANY ANALYSIS
7.1 Overview
7.2 Business Strategy
7.2.1 Point A
7.2.2 Point B
7.2.3 Point D
7.2.4 Point E
7.3 Financial Insight
8. SIEMENS HEALTHINEERS – COMPANY ANALYSIS
8.1 Overview
8.2 Business Strategy
8.2.1 Point A
8.2.2 Point B
8.2.3 Point C
8.3 Financial Insight
9. ROCHE DIAGNOSTICS – COMPANY ANALYSIS
9.1 Overview
9.2 Roche Holding AG Key Development
9.3 Business Strategy
9.3.1 Point A
9.3.2 Point B
9.3.3 Point C
9.4 Financial Insight
10. EUROIMMUN AG – COMPANY ANALYSIS
10.1 Overview
10.2 Business Strategy
10.2.1 Point A
10.2.2 Point B
10.3 Financial Insight
11. BIOMERIEUX SA – COMPANY ANALYSIS
11.1 Overview
11.2 Business Strategy
11.2.1 Point A
11.2.2 Point B
11.2.3 Point C
11.3 Financial Insight
12. QUEST DIAGNOSTIC – COMPANY ANALYSIS
12.1 Overview
12.2 Business Strategy
12.2.1 Point A
12.2.2 Point B
12.2.3 Point C
12.2.4 Point D
12.2.5 Point E
12.3 Financial Insight
13. BIO-RAD LABORATORIES – COMPANY ANALYSIS
13.1 Overview
13.2 Business Strategy
13.2.1 Point A
13.2.2 Point B
13.2.3 Point C
13.3 Financial Insight
14. GROWTH DRIVERS
14.1 Rising Incidence of Autoimmune Diseases
14.2 High Occurrence of Rheumatoid Arthritis
15. CHALLENGES
15.1 Industry Challenges by Product Differentiation
15.2 High Costs of Equipment for Diagnosis of Autoimmune Diseases
LIST OF FIGURES
Figure 2 1: Global Autoimmune Diseases Diagnostic Market (Billion US$), 2011 – 2018
Figure 2 2: Forecast for Global Autoimmune Diseases Diagnostic Market (Billion US$), 2019 – 2025
Figure 3 1: By Product - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2018
Figure 3 2: By Product - Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2019 – 2025
Figure 3 3: By Diseases – Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2018
Figure 3 4: By Diseases - Forecast for Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2019 – 2025
Figure 3 5: By Region - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2018
Figure 3 6: By Region – Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2018 – 2024
Figure 4 1: Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2018
Figure 4 2: Forecast for Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2019 - 2025
Figure 4 3: Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2011 - 2018
Figure 4 4: Forecast for Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2019 - 2025
Figure 4 5: Ankylosing Spondylitis disease diagnostics market (Million US$), 2011 - 2018
Figure 4 6: Forecast for Ankylosing Spondylitis disease diagnostics market (Million US$), 2019 – 2025
Figure 4 7: Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2011 – 2018
Figure 4 8: Forecast for Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2019 – 2025
Figure 4 9: Others Systemic autoimmune disease diagnostics market (Billion US$), 2011 – 2018
Figure 4 10: Forecast for Other Systemic autoimmune disease diagnostics market (Billion US$), 2019 – 2025
Figure 4 11: Localized Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2019
Figure 4 12: Forecast for Localized Autoimmune Disease Diagnostics Market (Billion US$), 2019 – 2025
Figure 4 13: Global – Inflammatory Bowel Disease Diagnostic Market (Million US$), 2011 - 2018
Figure 4 14: Global – Forecast for Inflammatory Bowel Disease Diagnostic Market (Million US$), 2019 - 2025
Figure 4 15: Global – Type 1 Diabetes Diagnostic Market (Million US$), 2011 – 2018
Figure 4 16: Global – Forecast for Type 1 Diabetes Diagnostic Market (Million US$), 2019 – 2025
Figure 4 17: Global – Thyroid Diagnosed Market (Million US$), 2011 – 2018
Figure 4 18: Global – Forecast for Thyroid Diagnosed Market (Million US$), 2019 – 2025
Figure 4 19: Global – Other Localized Autoimmune Disease Diagnostic Market (Million US$), 2011 – 2018
Figure 4 20: Global – Forecast for Other Localized Autoimmune Disease Diagnostic Market (Million US$), 2019 – 2025
Figure 5 1: Autoantibody Tests Market (Million US$), 2011 - 2018
Figure 5 2: Forecast for Autoantibody Tests Market (Million US$), 2019 – 2025
Figure 5 3: Antinuclear Antibody Tests Market (Million US$), 2011 - 2018
Figure 5 4: Forecast for Antinuclear Antibody Tests Market (Million US$), 2019 – 2025
Figure 5 5: Complete Blood Count Market (Million US$), 2011 – 2018
Figure 5 6: Forecast for Complete Blood Count Market (Million US$), 2019 – 2025
Figure 5 7: Erythrocyte Sedimentation Rate Market (Million US$), 2011 - 2018
Figure 5 8: Forecast for Erythrocyte Sedimentation Rate Market (Million US$), 2019 - 2025
Figure 5 9: C-reactive protein Test Market (Million US$), 2011 - 2018
Figure 5 10: Forecast for C-reactive protein Test Market (Million US$), 2019 - 2025
Figure 5 11: Urinalysis Market (Million US$), 2011 - 2018
Figure 5 12: Forecast for Urinalysis Market (Million US$), 2019 – 2025
Figure 5 13: Comprehensive Metabolic Panel Market (Million US$), 2011 - 2018
Figure 5 14: Forecast for Comprehensive Metabolic Panel Market (Million US$), 2019 - 2025
Figure 5 15: Others Autoimmune Diseases Test Market (Million US$), 2011 - 2018
Figure 5 16: Forecast for Others Autoimmune Diseases Test Market (Million US$), 2019 - 2025
Figure 6 1: North America Autoimmune Diseases Diagnostic Market (Billion US$), 2011 – 2018
Figure 6 2: Forecast for North America Autoimmune Diseases Diagnostic Market (Billion US$), 2019 – 2025
Figure 6 3: Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
Figure 6 4: Forecast for Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
Figure 6 5: Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
Figure 6 6: Forecast for Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
Figure 6 7: Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
Figure 6 8: Forecast for Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
Figure 7 1: Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2014 – 2018
Figure 7 2: Forecast for Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2019 – 2025
Figure 8 1: Siemens Healthineers ‘Healthcare’ Sales (Million USD) 2014 – 2018
Figure 8 2: Forecast for Siemens Healthineers ‘Healthcare’ Sales (Million USD) 2019 – 2025
Figure 9 1: Roche Diagnostics ‘Diagnostic’ Sales (Billion USD), 2014 – 2018
Figure 9 2: Forecast for Roche Diagnostics ‘Diagnostic’ Sales (Billion USD), 2019 – 2025
Figure 10 1: Euroimmun AG Net Sales (Million USD), 2014 – 2018
Figure 10 2: Forecast for Euroimmun AG Net Sales (Million US$), 2019 – 2025
Figure 11 1: biomerieux SA Net Sales (Million USD), 2014 – 2018
Figure 11 2: Forecast for biomerieux SA Net Sales (Million USD), 2019 – 2025
Figure 12 1: Quest Diagnostic Net Sales (Million US$), 2014 – 2018
Figure 12 2: Forecast for Quest Diagnostic Net Sales (Million US$), 2019 – 2025
Figure 13 1: Bio-Red Laboratories Net Sales (Million US$), 2014 – 2019
Figure 13 2: Forecast for Bio-Red Laboratories Net Sales (Million US$), 2019 – 2025
Figure 14 1: Prevalence of Diagnosed Autoimmune Conditions in Selected Countries as of 2017
Figure 14 2: Arthritis in U.S (Million) 2017 – 2024
Figure 14 3: Prevalence of rheumatoid arthritis, by age and sex, 2014–15
Figure 2 1: Global Autoimmune Diseases Diagnostic Market (Billion US$), 2011 – 2018
Figure 2 2: Forecast for Global Autoimmune Diseases Diagnostic Market (Billion US$), 2019 – 2025
Figure 3 1: By Product - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2018
Figure 3 2: By Product - Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2019 – 2025
Figure 3 3: By Diseases – Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2018
Figure 3 4: By Diseases - Forecast for Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2019 – 2025
Figure 3 5: By Region - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 – 2018
Figure 3 6: By Region – Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2018 – 2024
Figure 4 1: Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2018
Figure 4 2: Forecast for Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2019 - 2025
Figure 4 3: Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2011 - 2018
Figure 4 4: Forecast for Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2019 - 2025
Figure 4 5: Ankylosing Spondylitis disease diagnostics market (Million US$), 2011 - 2018
Figure 4 6: Forecast for Ankylosing Spondylitis disease diagnostics market (Million US$), 2019 – 2025
Figure 4 7: Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2011 – 2018
Figure 4 8: Forecast for Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2019 – 2025
Figure 4 9: Others Systemic autoimmune disease diagnostics market (Billion US$), 2011 – 2018
Figure 4 10: Forecast for Other Systemic autoimmune disease diagnostics market (Billion US$), 2019 – 2025
Figure 4 11: Localized Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2019
Figure 4 12: Forecast for Localized Autoimmune Disease Diagnostics Market (Billion US$), 2019 – 2025
Figure 4 13: Global – Inflammatory Bowel Disease Diagnostic Market (Million US$), 2011 - 2018
Figure 4 14: Global – Forecast for Inflammatory Bowel Disease Diagnostic Market (Million US$), 2019 - 2025
Figure 4 15: Global – Type 1 Diabetes Diagnostic Market (Million US$), 2011 – 2018
Figure 4 16: Global – Forecast for Type 1 Diabetes Diagnostic Market (Million US$), 2019 – 2025
Figure 4 17: Global – Thyroid Diagnosed Market (Million US$), 2011 – 2018
Figure 4 18: Global – Forecast for Thyroid Diagnosed Market (Million US$), 2019 – 2025
Figure 4 19: Global – Other Localized Autoimmune Disease Diagnostic Market (Million US$), 2011 – 2018
Figure 4 20: Global – Forecast for Other Localized Autoimmune Disease Diagnostic Market (Million US$), 2019 – 2025
Figure 5 1: Autoantibody Tests Market (Million US$), 2011 - 2018
Figure 5 2: Forecast for Autoantibody Tests Market (Million US$), 2019 – 2025
Figure 5 3: Antinuclear Antibody Tests Market (Million US$), 2011 - 2018
Figure 5 4: Forecast for Antinuclear Antibody Tests Market (Million US$), 2019 – 2025
Figure 5 5: Complete Blood Count Market (Million US$), 2011 – 2018
Figure 5 6: Forecast for Complete Blood Count Market (Million US$), 2019 – 2025
Figure 5 7: Erythrocyte Sedimentation Rate Market (Million US$), 2011 - 2018
Figure 5 8: Forecast for Erythrocyte Sedimentation Rate Market (Million US$), 2019 - 2025
Figure 5 9: C-reactive protein Test Market (Million US$), 2011 - 2018
Figure 5 10: Forecast for C-reactive protein Test Market (Million US$), 2019 - 2025
Figure 5 11: Urinalysis Market (Million US$), 2011 - 2018
Figure 5 12: Forecast for Urinalysis Market (Million US$), 2019 – 2025
Figure 5 13: Comprehensive Metabolic Panel Market (Million US$), 2011 - 2018
Figure 5 14: Forecast for Comprehensive Metabolic Panel Market (Million US$), 2019 - 2025
Figure 5 15: Others Autoimmune Diseases Test Market (Million US$), 2011 - 2018
Figure 5 16: Forecast for Others Autoimmune Diseases Test Market (Million US$), 2019 - 2025
Figure 6 1: North America Autoimmune Diseases Diagnostic Market (Billion US$), 2011 – 2018
Figure 6 2: Forecast for North America Autoimmune Diseases Diagnostic Market (Billion US$), 2019 – 2025
Figure 6 3: Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
Figure 6 4: Forecast for Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
Figure 6 5: Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
Figure 6 6: Forecast for Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
Figure 6 7: Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
Figure 6 8: Forecast for Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
Figure 7 1: Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2014 – 2018
Figure 7 2: Forecast for Abbot Laboratories ‘Diagnostics’ Sales (Million US$), 2019 – 2025
Figure 8 1: Siemens Healthineers ‘Healthcare’ Sales (Million USD) 2014 – 2018
Figure 8 2: Forecast for Siemens Healthineers ‘Healthcare’ Sales (Million USD) 2019 – 2025
Figure 9 1: Roche Diagnostics ‘Diagnostic’ Sales (Billion USD), 2014 – 2018
Figure 9 2: Forecast for Roche Diagnostics ‘Diagnostic’ Sales (Billion USD), 2019 – 2025
Figure 10 1: Euroimmun AG Net Sales (Million USD), 2014 – 2018
Figure 10 2: Forecast for Euroimmun AG Net Sales (Million US$), 2019 – 2025
Figure 11 1: biomerieux SA Net Sales (Million USD), 2014 – 2018
Figure 11 2: Forecast for biomerieux SA Net Sales (Million USD), 2019 – 2025
Figure 12 1: Quest Diagnostic Net Sales (Million US$), 2014 – 2018
Figure 12 2: Forecast for Quest Diagnostic Net Sales (Million US$), 2019 – 2025
Figure 13 1: Bio-Red Laboratories Net Sales (Million US$), 2014 – 2019
Figure 13 2: Forecast for Bio-Red Laboratories Net Sales (Million US$), 2019 – 2025
Figure 14 1: Prevalence of Diagnosed Autoimmune Conditions in Selected Countries as of 2017
Figure 14 2: Arthritis in U.S (Million) 2017 – 2024
Figure 14 3: Prevalence of rheumatoid arthritis, by age and sex, 2014–15
LIST OF TABLES
Table 4 1: Human Systemic Autoimmune Diseases
Table 4 2: Human Localized Autoimmune Diseases
Table 5 1: Normal Complete Blood Count Result
Table 8 1: Prevalence Data for Selected Autoimmune Diseases Listed - 2010
Table 8 2: US Prevalence Data for Selected Autoimmune Diseases Listed - 2012
Table 4 1: Human Systemic Autoimmune Diseases
Table 4 2: Human Localized Autoimmune Diseases
Table 5 1: Normal Complete Blood Count Result
Table 8 1: Prevalence Data for Selected Autoimmune Diseases Listed - 2010
Table 8 2: US Prevalence Data for Selected Autoimmune Diseases Listed - 2012
